STEPHANIE SWOPE: Open Payments
NPI 1811439045 · SENECA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 27 payments from 14 companies in 2025. Trend: 2023 $63 · 2024 $1,172 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| PFIZER INC. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $30 |
| Novo Nordisk Inc | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: LINZESS, REXULTI, TRELEGY ELLIPTA, BREZTRI, ELIQUIS, Veozah, VOQUEZNA, GEMTESA.
Industry payments across PA — which companies pay providers there.
